You Searched For "vaccine maker bharat biotech" and got 20 results
Sort By:
Danish monkeypox-vaccine maker surges 17% after global health emergency declared
Bavarian Nordic extended its two-day gain to 31% on the WHO news as the company's CEO pledged to pr…
Filip De Mott
Bharat Biotech's intranasal Covid vaccine approved by govt, to be available on CO-WIN
Prime Minister Narendra Modi had on Thursday cautioned people against complacency and urged…
PTI
BHU study on Covaxin side effects poorly designed, critically flawed: ICMR Director General
The Indian Council of Medical Research Director General Dr Rajiv Bahl has criticised a recently pub…
PTI
Biological E, Bharat Biotech together sitting on stockpile of 250 million COVID vaccine doses
stockpile of 50 million doses of Covaxin. Dr Vikram Paradkar, Executive Vice President (M…
PTI
Bharat Biotech's nasal Covid vaccine to be priced at ₹800 for private and ₹325 for govt hospitals
Bharat Biotech's nasal COVID-19 vaccine iNCOVACC, which was given approval as a booster dose, will …
ANI
Chinese hackers target Indian vaccine makers SII and Bharat Biotech: Report
Both SII and Bharat Biotech are involved in producing Covid-19 vaccine. Moreover, Cyfirma add…
Bharat Biotech to make antigen for first-ever anti-malaria vaccine
The first dose of the vaccine has reached more than 500,000 children since the pilots we…
Ideal time for COVID-19 booster shot is six months after the second dose, says Bharat Biotech MD
"The ideal time for a booster dose is six months after the second dose," Ella stated. Abo…
PTI
Bharat Biotech working on TB vaccine, to ink pact with a firm for technology
"Our honourable Prime Minister (Narendra Modi) has got an agenda of 2025 for the eradication of tub…
PTI
Russian vaccine makers are trying to push AstraZeneca COVID-19 vaccine's efficacy to beyond 90%
With the Drug Controller General of India (DCGI) approving Serum Institute of India's 'Covishield' …
WHO approves Bharat Biotech’s Covaxin for emergency use after a long wait
The WHO, in a tweet, said: "WHO has granted emergency use listing (EUL) to Covaxin, developed by…
Bharat Biotech’s Covaxin shows 81% efficacy after second dose in phase 3 trials
Hyderabad-based Bharat Biotech released phase 3 results of its Covid-19 vaccine — Covaxin — today. …
Supreme Court wants the Indian government to explain vaccine pricing — and clarify how many doses it will need as coverage expands from May 1
The Supreme Court of India has decided it cannot be a “mute spectator” as the number of new COVID-1…
Health Ministry rejects claim 'Covaxin was rushed due to political pressure'
The Union Health Ministry on Thursday rejected media reports that Covaxin manufacturer Bharat Biote…
Russian, North Korean hackers target COVID vaccine maker in India, alleges Microsoft
According to Microsoft, among the targets, the majority are vaccine makers that have Covid-1…
Rivals Serum Institute and Bharat Biotech come together after fear of ban on vaccine exports
Bharat Biotech CEO Krishna Ella and Serum Institute of India (SII) CEO Adar Poonawalla issued a joi…
Covaxin supply to government at ₹150 per dose is not sustainable, says Bharat Biotech
The supply price of Covaxin to the government of India at Rs 150 a dose is a non-competitive price …
The success story of Cyrus Poonawalla: The vaccine king who is one of the world’s richest billionaires
India’s vaccine king tried to make an affordable Jaguar but chose to go for a ‘product of the masse…
OPINION: No matter what Bharat Biotech says, Covaxin is just not ready for approvals
Benefits like how effective the vaccine is in preventing disease, and risks such as high morta…
After Serum Institute of India, Bharat Biotech says it will reduce the cost of COVAXIN for state governments
Bharat Biotech, the company behind the COVID-19 vaccine COVAXIN, has slashed the price of its vacci…